Treating COPD in Older and Oldest Old Patients

被引:25
|
作者
Corsonello, Andrea [1 ]
Scarlata, Simone [2 ]
Pedone, Claudio [2 ]
Bustacchini, Silvia [3 ]
Fusco, Sergio [1 ]
Zito, Anna [2 ]
Incalzi, Raffaele Antonelli [2 ]
机构
[1] INRCA, Unit Geriatr Pharmacoepidemiol, Cosenza, Italy
[2] Univ Campus Biomedico, Chair Geriatr Med, Rome, Italy
[3] INRCA, Sci Direct, Cosenza, Italy
关键词
Older; chronic obstructive pulmonary disease (COPD); long-acting antichilinergics (LAMA); long-acting beta agonists (LABA); comorbidity; adherence; OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; METERED-DOSE INHALER; PRACTICAL MANAGEMENT PROBLEMS; CHRONIC RESPIRATORY-FAILURE; CONTINUOUS OXYGEN-THERAPY; CILIARY BEAT FREQUENCY; AIR-FLOW OBSTRUCTION; DRY POWDER INHALERS; ACUTE EXACERBATIONS;
D O I
10.2174/1381612821666150130121229
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The treatment of older and oldest old patients with COPD poses several problems and should be tailored to specific outcomes, such as physical functioning. Indeed, impaired homeostatic mechanisms, deteriorated physiological systems, and limited functional reserve mainly contribute to this complex scenario. Therefore, we reviewed the main difficulties in managing therapy for these patients and possible remedies. Inhaled long acting beta-agonists (LABA) and anticholinergics (LAMA) are the mainstay of therapy in stable COPD, but it should be considered that pharmacological response and safety profile may vary significantly in older patients with multimorbidity. Their association with inhaled corticosteroids is recommended only for patients with severe or very severe airflow limitation or with frequent exacerbations despite bronchodilator treatment. In hypoxemic patients, long-term oxygen therapy (LTOT) may improve not only general comfort and exercise tolerance, but also cognitive functions and sleep. Non-pharmacological interventions, including education, physical exercise, nutritional support, pulmonary rehabilitation and telemonitoring can importantly contribute to improve outcomes. Older patients with COPD should be systematically evaluated for the presence of risk factors for non-adherence, and the inhaler device should be chosen very carefully. Comorbidities, such as cardiovascular diseases, chronic kidney disease, osteoporosis, obesity, cognitive, visual and auditory impairment, may significantly affect treatment choices and should be scrutinized. Palliative care is of paramount importance in end-stage COPD. Finally, treatment of COPD exacerbations has been also reviewed. Therapeutic decisions should be founded on a careful assessment of cognitive and functional status, comorbidity, polypharmacy, and age-related changes in pharmacokinetics and pharmacodynamics in order to minimize adverse drug events, drug-drug or drug-disease interactions, and non-adherence to treatment.
引用
收藏
页码:1672 / 1689
页数:18
相关论文
共 50 条
  • [1] Treating Diabetes Mellitus in Older and Oldest Old Patients
    Abbatecola, A. M.
    Paolisso, G.
    Sinclair, A. J.
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (13) : 1665 - 1671
  • [2] Treating Heart Failure in Older and Oldest Old Patients
    Vetrano, Davide Liborio
    Lattanzio, Fabrizia
    Martone, Anna Maria
    Landi, Francesco
    Brandi, Vincenzo
    Topinkova, Eva
    Onder, Graziano
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (13) : 1659 - 1664
  • [3] Treating Major Age-Related Diseases in Older and Oldest Old Patients.
    Corsonello, Andrea
    Cherubini, Antonio
    Lattanzio, Fabrizia
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (13) : 1656 - 1658
  • [4] Treating COPD in Chronic Patients in a Primary-Care Setting
    Llauger Rosello, Maria Antonia
    Antonia Pou, Maria
    Dominguez, Leandra
    Freixas, Montse
    Valverde, Pepi
    Valero, Carles
    ARCHIVOS DE BRONCONEUMOLOGIA, 2011, 47 (11): : 561 - 570
  • [5] Identifying and Treating COPD in Cardiac Patients
    Nozzoli, Carlo
    Beghe, Bianca
    Boschetto, Piera
    Fabbri, Leonardo M.
    CHEST, 2013, 144 (03) : 723 - 726
  • [6] Current Status of Gastrectomy for Gastric Cancer in Oldest-old Patients Aged 85 Years or Older
    Kazuaki Matsui
    Yoshiki Kawaguchi
    Takahiro Iwai
    Yukiko Torizaki
    Yoko Adachi
    Hirofumi Shimoda
    Takehiro Shimada
    Yasuhito Sekimoto
    Hidejiro Urakami
    Shiko Seki
    Journal of Gastrointestinal Cancer, 2025, 56 (1)
  • [7] Inhaler Devices for Patients with COPD
    Fink, James B.
    Colice, Gene L.
    Hodder, Rick
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2013, 10 (04) : 523 - 535
  • [8] Advancing care: optimizing osteoporosis treatment in the older and oldest old population
    Claudia Panait
    Patrizia D’Amelio
    Aging Clinical and Experimental Research, 37 (1)
  • [9] Symptom frequency and change of oldest old cancer patients
    Pang, Linda
    de la Cruz, Maxine
    Wu, Jimin
    Liu, Diane
    Naqvi, Mujtaba
    Bruera, Eduardo
    SUPPORTIVE CARE IN CANCER, 2019, 27 (11) : 4165 - 4170
  • [10] Quality of Life in European Older Adults of SHARE Wave 7: Comparing the Old and the Oldest-Old
    Oliver, Amparo
    Sentandreu-Mano, Trinidad
    Tomas, Jose M.
    Fernandez, Irene
    Sancho, Patricia
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (13)